EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer

Kamil Cebulski iD, Aleksandra Piotrowska iD, Alicja Kmiecik, Katarzyna Haczkiewicz-Leśniak iD, Urszula Ciesielska, Jędrzej Grzegrzółka, Karolina Jabłońska, Hanna Romanowicz, Beata Smolarz iD, Piotr Dzięgiel, Marzenna Podhorska-Okołów, Katarzyna Nowińska iD

International Journal of Molecular Sciences · 11.05.2023 · 24 (10) · 8628

DOI: 10.3390/ijms24108628 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.05.2023. Verfasst von Kamil Cebulski und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University, Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irisin (Ir) is an adipomyokine formed from fibronectin type III domain-containing protein 5 (FNDC5), which can be found in various cancer tissues. Additionally, FNDC5/Ir is suspected of inhibiting the epithelial-mesenchymal transition (EMT) process. This relationship has been poorly studied for breast cancer (BC). The ultrastructural cellular localizations of FNDC5/Ir were examined in BC tissues and BC cell lines. Furthermore, we compared serum levels of Ir with FNDC5/Ir expression in BC tissues. The aim of this study was to examine the levels of EMT markers, such as E-cadherin, N-cadherin, SNAIL, SLUG, and TWIST, and to compare their expression levels with FNDC5/Ir in BC tissues. Tissue microarrays with 541 BC samples were used to perform immunohistochemical reactions. Serum levels of Ir were assessed in 77 BC patients. We investigated FNDC5/Ir expression and ultrastructural localization in MCF-7, MDA-MB-231, and MDA-MB-468 BC cell lines and in the normal breast cell line (Me16c), which was used as the control. FNDC5/Ir was present in BC cell cytoplasm and tumor fibroblasts. FNDC5/Ir expression levels in BC cell lines were higher compared to those in the normal breast cell line. Serum Ir levels did not correlate with FNDC5/Ir expression in BC tissues but were associated with lymph node metastasis (N) and histological grade (G). We found that FNDC5/Ir correlated moderately with E-cadherin and SNAIL. Higher Ir serum level is associated with lymph node metastasis and increased grade of malignancy. FNDC5/Ir expression is associated with E-cadherin expression level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleFibronectinsLymphatic MetastasisCell Line, TumorTranscription FactorsCadherinsEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

E-cadherinEMTFNDC5SLUGSNAILTWISTbreast cancer (BC)irisin

Substanzen

FibronectinsTranscription FactorsCadherinsFNDC5 protein, human

Autor:innen und Institutionen

  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Division of Ultrastructural Research, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Department of Pathology, Polish Mother Memorial Hospital-Research Institute, 93-338 Lodz, Poland.
  • Department of Human Biology, Faculty of Physiotherapy, Wroclaw University of Health and Sport Sciences, 51-612 Wroclaw, Poland.

ORCID-Profile: Kamil Cebulski, Aleksandra Piotrowska, Katarzyna Haczkiewicz-Leśniak, Beata Smolarz, Katarzyna Nowińska

Förderung

  • Wroclaw Medical University
  • Ministry of Education and Science

Zitieren

APA

Cebulski, K., Piotrowska, A., Kmiecik, A., Haczkiewicz-Leśniak, K., Ciesielska, U., Grzegrzółka, J., Jabłońska, K., Romanowicz, H., Smolarz, B., Dzięgiel, P., Podhorska-Okołów, M., & Nowińska, K. (2023). The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer. International Journal of Molecular Sciences, 24(10), 8628. https://doi.org/10.3390/ijms24108628

Vancouver

Cebulski K, Piotrowska A, Kmiecik A, Haczkiewicz-Leśniak K, Ciesielska U, Grzegrzółka J, et al. The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer. International Journal of Molecular Sciences. 2023;24(10):8628. doi:10.3390/ijms24108628

BibTeX
@article{Cebulski2023,
  author = {Cebulski, Kamil and Piotrowska, Aleksandra and Kmiecik, Alicja and Haczkiewicz-Leśniak, Katarzyna and Ciesielska, Urszula and Grzegrzółka, Jędrzej and Jabłońska, Karolina and Romanowicz, Hanna and Smolarz, Beata and Dzięgiel, Piotr and Podhorska-Okołów, Marzenna and Nowińska, Katarzyna},
  title = {The Role of Irisin/FNDC5 Expression and Its Serum Level in Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {10},
  pages = {8628},
  doi = {10.3390/ijms24108628}
}
Kostenlos starten →